EXPERIMENTAL EYE RESEARCH

Scope & Guideline

Connecting Cellular Mechanisms to Visual Processes

Introduction

Delve into the academic richness of EXPERIMENTAL EYE RESEARCH with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0014-4835
PublisherACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1961 to 2024
AbbreviationEXP EYE RES / Exp. Eye Res.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address24-28 OVAL RD, LONDON NW1 7DX, ENGLAND

Aims and Scopes

The journal 'Experimental Eye Research' focuses on advancing knowledge in ocular biology, diseases, and therapies through innovative experimental research. Its main aims include publishing studies that explore the molecular, cellular, and systemic aspects of eye health and disease, as well as potential therapeutic interventions.
  1. Ocular Genetics and Molecular Biology:
    Research on genetic factors influencing ocular diseases, exploring gene mutations, and their impacts on retinal and corneal health.
  2. Retinal and Corneal Physiology:
    Studies investigating the physiological mechanisms underlying retinal function, corneal integrity, and the effects of various treatments on these structures.
  3. Therapeutic Interventions and Drug Delivery:
    Focus on novel therapeutic approaches, including drug delivery systems, gene therapy, and the use of stem cells to treat ocular diseases.
  4. Pathophysiology of Ocular Diseases:
    Investigation of the underlying mechanisms of diseases such as glaucoma, diabetic retinopathy, and age-related macular degeneration.
  5. Immunology and Inflammation:
    Research into the role of immune responses and inflammation in ocular diseases, including the development of therapeutic strategies to mitigate these effects.
  6. Innovative Imaging Techniques:
    Development and application of advanced imaging modalities to study ocular structures and functions in health and disease.
The journal has identified several emerging themes and trends in ocular research, reflecting advancements in technology, molecular biology, and therapeutic strategies. This section outlines the prominent areas gaining traction within recent publications.
  1. Gene Therapy and Genetic Engineering:
    An increasing number of studies focus on gene therapy as a novel approach for treating inherited retinal diseases, showcasing advances in CRISPR technology and viral vectors.
  2. Regenerative Medicine and Stem Cell Therapy:
    Research exploring the use of stem cells and regenerative techniques to repair ocular tissues and restore vision is gaining significant attention.
  3. Ocular Microbiome and Its Role in Disease:
    Emerging studies on the ocular microbiome and its implications for eye health, disease, and treatment strategies are becoming more prevalent.
  4. Ocular Drug Delivery Systems:
    There is a growing emphasis on innovative drug delivery systems, including nanoparticles and microneedles, to enhance the efficacy of ocular therapies.
  5. Inflammation and Immunology in Ocular Diseases:
    Increased focus on the role of inflammation and immune responses in ocular diseases, with research exploring novel anti-inflammatory therapies.
  6. Artificial Intelligence and Imaging:
    The integration of AI and advanced imaging techniques for diagnosis and monitoring of ocular diseases reflects a significant trend in enhancing clinical outcomes.

Declining or Waning

While 'Experimental Eye Research' covers a broad spectrum of topics, certain themes appear to be declining in prominence over recent years. This section highlights those areas that have seen reduced publication frequency or interest.
  1. Traditional Pharmacology Studies:
    Research focused solely on classical pharmacological approaches without incorporating novel drug delivery systems or molecular biology insights seems to be less frequent.
  2. Basic Histopathology of Ocular Tissues:
    Studies concentrating solely on histopathological descriptions without integrating functional or molecular insights are appearing less, as the field shifts towards more comprehensive approaches.
  3. Animal Models with Limited Relevance to Human Disease:
    There is a declining trend in studies utilizing animal models that do not adequately mimic human ocular diseases, as researchers seek more relevant translational models.
  4. Non-Experimental Reviews:
    The journal has seen a decrease in the publication of purely review articles that do not present new experimental data or insights, reflecting a shift towards more data-driven research.

Similar Journals

OPHTHALMOLOGICA

Connecting Disciplines to Enhance Vision Care
Publisher: KARGERISSN: 0030-3755Frequency: 6 issues/year

OPHTHALMOLOGICA is a prestigious journal published by KARGER, dedicated to the dynamic field of ophthalmology and its interdisciplinary connections with medicine and sensory systems. With a rich history spanning over a century since its inception in 1899, this journal is esteemed for its high-quality research and impactful contributions, maintaining an impressive Q1 quartile ranking in both ophthalmology and miscellaneous medicine as of 2023, alongside a notable Q2 status in sensory systems. The journal's influence is reinforced by its Scopus rankings, where it ranks 26th out of 137 in ophthalmology, showcasing a strong percentile position of 81. Based in Basel, Switzerland, OPHTHALMOLOGICA serves as an essential platform for researchers, professionals, and students, providing essential insights, reviews, and studies that push the boundaries of knowledge in the vision sciences. Although it does not currently offer open access, its contributions are critical for those pursuing advancements in ocular health and related disciplines.

BRITISH JOURNAL OF OPHTHALMOLOGY

Advancing Vision: Bridging Research and Practice
Publisher: BMJ PUBLISHING GROUPISSN: 0007-1161Frequency: 12 issues/year

The British Journal of Ophthalmology, published by the BMJ Publishing Group, stands as a leading peer-reviewed journal in the field of ocular sciences, with a distinctive focus on advancing the understanding of vision and its impairment. With a rich history dating back to 1941, this journal serves as an essential platform for researchers, professionals, and students in ophthalmology and related disciplines. It prominently ranks in the Q1 quartile for Ophthalmology and Cellular and Molecular Neuroscience in 2023, reflecting its esteemed reputation in the scientific community. The journal boasts impressive Scopus rankings, including Rank #6 in Medicine - Ophthalmology, showcasing its influential contributions to the field. Although it does not offer open access, the journal is committed to disseminating high-quality research that informs clinical practices and enriches the understanding of sensory systems. Submissions are encouraged from all areas of ophthalmology, including clinical studies, innovative research, and systemic reviews. Join the vibrant academic dialogue by engaging with the cutting-edge findings published in the British Journal of Ophthalmology, which aims to bridge the gap between research and clinical application.

Expert Review of Ophthalmology

Navigating the Evolving Landscape of Ophthalmology
Publisher: ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTDISSN: 1746-9899Frequency: 6 issues/year

Expert Review of Ophthalmology is a leading academic journal published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, specializing in the rapidly evolving field of ophthalmology. With its ISSN 1746-9899 and E-ISSN 1746-9902, this journal has been at the forefront of disseminating critical research and insightful reviews since its inception in 2006. Covering a broad spectrum of topics within ophthalmology, it plays a pivotal role in advancing knowledge and practice, especially given its prestigious standings in various quartile rankings, including Q1 in Public Health and Q2 in Immunology and Allergy for 2023. The journal aims to provide professionals, researchers, and students with comprehensive perspectives on contemporary challenges and innovations in ophthalmology. Generously supported by a robust peer-review process, the journal ensures that all published works meet high academic standards, thereby serving as a vital resource for anyone looking to stay informed about the latest developments in eye care and vision science. By bridging research and clinical application, Expert Review of Ophthalmology is essential for those aiming to contribute meaningfully to this critical field.

Turk Oftalmoloji Dergisi-Turkish Journal of Ophthalmology

Empowering Ophthalmologists with Cutting-Edge Insights
Publisher: GALENOS PUBL HOUSEISSN: 1300-0659Frequency: 6 issues/year

Turk Oftalmoloji Dergisi - Turkish Journal of Ophthalmology is a premier peer-reviewed publication dedicated to the field of ophthalmology, published by GALENOS PUBL HOUSE. Since its inception in 1997, this Open Access journal has championed the dissemination of high-quality research, fostering an inclusive environment for sharing knowledge and advancements in eye health. With an ISSN of 1300-0659 and an E-ISSN of 2147-2661, the journal serves as a vital resource for researchers, clinicians, and students interested in the latest findings and innovations in ophthalmic sciences. Although its coverage in Scopus has been discontinued since 2017, the journal has garnered a significant rank of 80 out of 114 in the field of Medicine – Ophthalmology, highlighting its relevance and impact within the discipline. Operating out of Istanbul, Turkey, the Turkish Journal of Ophthalmology continues to be a crucial platform for ophthalmologists and researchers to publish their work and advance the understanding of ocular health.

Translational Vision Science & Technology

Shaping the Future of Ophthalmology Through Innovation
Publisher: ASSOC RESEARCH VISION OPHTHALMOLOGY INCISSN: 2164-2591Frequency: 6 issues/year

Translational Vision Science & Technology is a premier open access journal dedicated to the advancement of the field of ophthalmology and biomedical engineering. Published by the Association for Research in Vision and Ophthalmology, Inc., this journal has established itself as a leading source of high-quality research since its inception in 2013, achieving a remarkable impact factor reflective of its influential contribution to the field. With an impressive ranking of #21 in Ophthalmology and #120 in Biomedical Engineering within the Scopus database, it sits within the prestigious Q1 quartile for both categories as of 2023, further validating its significance. The journal's scope encompasses a wide variety of topics focused on the intersection of ophthalmological science and technological innovation, welcoming contributions that promote the understanding and treatment of visual disorders. Available as an Open Access publication since 2016, it ensures that cutting-edge research is freely accessible to researchers, practitioners, and students worldwide, facilitating the rapid dissemination of knowledge essential for the advancement of vision science.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Fostering Excellence in Ophthalmic Research
Publisher: SPRINGERISSN: 0721-832XFrequency: 12 issues/year

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, published by Springer, has established itself as a premier journal in the field of ophthalmology since its inception in 1870. With an ISSN of 0721-832X and an E-ISSN of 1435-702X, this esteemed journal enjoys a notable impact in the research community, ranking Q1 in Ophthalmology and Q1 in Sensory Systems, as per the latest 2023 journal category quartiles. GRAEFES Archive is dedicated to advancing our understanding of ocular health through both clinical and experimental studies, making it an essential resource for researchers, practitioners, and students alike. Its comprehensive scope covers various aspects of ophthalmic science, reflecting its long-standing commitment to quality and excellence. Although it currently operates on a subscription basis, the journal's significant Scopus rankings—24th out of 137 in Ophthalmology—underscore its relevance and influence within the scientific community. Situated in Germany, with its address in the United States, this international journal continues to shape the discourse on vision science and therapeutic innovation.

CORNEA

Leading the way in ophthalmology with impactful studies.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0277-3740Frequency: 12 issues/year

CORNEA is a prestigious peer-reviewed journal published by Lippincott Williams & Wilkins, focusing on the rapidly advancing field of ophthalmology with a particular emphasis on corneal research and diseases. With an impact factor categorized in the prestigious Q1 quartile for its discipline, CORNEA has established itself as a leading platform for the dissemination of both fundamental and clinical studies since its inception in 1982. The journal is ranked 25th out of 137 in the Scopus Medicine-Ophthalmology category, placing it in the 82nd percentile among its peers, which underscores its vital role in influencing ocular research and clinical practices. While the journal is not currently open access, it provides valuable insights and updates for professionals, researchers, and students working to advance knowledge in corneal health, contributing significantly to the ongoing dialogue in the ophthalmological community. With a commitment to excellence, CORNEA continues to publish high-quality research and reviews in its pursuit to improve ocular outcomes and patient care.

MOLECULAR VISION

Championing open access to elevate ocular health advancements.
Publisher: MOLECULAR VISIONISSN: 1090-0535Frequency: 1 issue/year

MOLECULAR VISION is a premier open-access journal that has been advancing the field of ophthalmology since its inception in 1995. Published by MOLECULAR VISION, this journal boasts a strong reputation, currently ranking in the second quartile (Q2) of its category, with a Scopus ranking of 35 out of 137, placing it in the 74th percentile among peer publications. Dedicated to disseminating groundbreaking research and innovative findings in the study of vision and ocular health, MOLECULAR VISION serves as a vital resource for researchers, healthcare professionals, and students engaged in this dynamic field. The journal welcomes contributions spanning fundamental and clinical research, offering a platform for crucial knowledge exchange that is essential for advancing ocular health and function. With its commitment to open access, readers around the globe can freely access and build upon the wealth of information disseminated through its pages, ensuring that the latest developments in ophthalmology are available to all.

PROGRESS IN RETINAL AND EYE RESEARCH

Driving Breakthroughs in Sensory Systems
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 1350-9462Frequency: 6 issues/year

PROGRESS IN RETINAL AND EYE RESEARCH, published by PERGAMON-ELSEVIER SCIENCE LTD, is a premier journal dedicated to the advancement of knowledge in the fields of ophthalmology and sensory systems. With an impressive impact factor and a Q1 category ranking in both Ophthalmology and Sensory Systems as of 2023, this journal exemplifies excellence in research dissemination. Given its stature, it ranks #1 out of 137 in Ophthalmology and #1 out of 42 in Neuroscience - Sensory Systems, placing it within the top percentile of scientific publications in these domains. The journal has been actively contributing to the field since its inception in 1994 and continues to be a vital resource for researchers, clinicians, and students seeking the latest insights and breakthroughs in the understanding of retinal diseases and eye health. While it maintains a traditional subscription model, the journal remains committed to publishing high-quality, peer-reviewed articles that drive forward the frontiers of eye research and therapeutic innovation. With its strong scientific rigor and a vast array of articles, PROGRESS IN RETINAL AND EYE RESEARCH is indispensable for anyone invested in the study of visual sciences.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE

Advancing the frontiers of vision science.
Publisher: ASSOC RESEARCH VISION OPHTHALMOLOGY INCISSN: 0146-0404Frequency: 12 issues/year

Investigative Ophthalmology & Visual Science (IOVS) is a leading academic journal published by the Association for Research in Vision and Ophthalmology, dedicated to advancing the field of ophthalmology and visual science. With an impressive impact factor and ranking in the Q1 category for both Ophthalmology and Sensory Systems, IOVS is well-respected for disseminating cutting-edge research and innovative discoveries. Established in 1977, this Open Access journal allows for broad accessibility to pioneering studies, fostering collaboration among researchers, clinicians, and students. The journal has consistently maintained high visibility in the academic community, evidenced by its robust rankings in Scopus, including Rank #16 in Ophthalmology. As it continues to pave the way for future developments in the understanding and treatment of ocular diseases, IOVS serves as an invaluable resource for those immersed in the complex field of visual science.